Form 6K Nyxoah SA For: 16 June
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Nyxoah (NYXH)
Nyxoah stock price live, this page displays EBR NYXH stock exchange data. View the NYXH premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Nyxoah real time stock price chart below.
What Is the Nyxoah Stock Price Today?
The Nyxoah stock price today is 7.58.
What Is the Stock Symbol for Nyxoah?
The stock symbol for Nyxoah is ""NYXH.""
What Stock Exchange Does Nyxoah Trade On?
Nyxoah is listed and trades on the Brussels stock exchange.
Is Nyxoah a Good Stock to Buy?
Determining whether Nyxoah—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NYXH quote. (ISIN: BE0974358906)
What Is the Nyxoah Stock Price Today?
The Nyxoah stock price today is 7.58.
What Is the Stock Symbol for Nyxoah?
The stock symbol for Nyxoah is ""NYXH.""
What Stock Exchange Does Nyxoah Trade On?
Nyxoah is listed and trades on the Brussels stock exchange.
Is Nyxoah a Good Stock to Buy?
Determining whether Nyxoah—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NYXH quote. (ISIN: BE0974358906)
7.58
-0.21(-2.70%)
Closed·
After Hours
7.580.00(0.00%)
·
Fair Value
An estimate of a Nyxoah's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.50
7.77
52 wk Range
5.55
11.87
NYXH Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 9 days
More Info
Fair Value
An estimate of a Nyxoah's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.507.77
52 wk Range
5.5511.87
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
NYXH Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Nyxoah's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
- Nyxoah NAQ receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form 6K Nyxoah SA For: 2 June
- Investing.com
- Conditional Issuance of Shares
- Investing.com
- Form 6K Nyxoah SA For: 16 June
- Investing.com
- Form 6K Nyxoah SA For: 2 June
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Nyxoah Company Profile
Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Nyxoah SWOT Analysis
Innovative OSA Solution | Explore Nyxoah's Genio system, a groundbreaking bilateral neurostimulation approach for treating obstructive sleep apnea, challenging traditional therapies |
Market Expansion Hurdles | Delve into Nyxoah's European market challenges, including recent setbacks in Germany, and its strategic preparations for U.S. market entry |
Financial Outlook | Analysts project an average price target of $16.33, with Nyxoah forecasting sales growth from €5.6 million in 2024 to €37.0 million in 2025 |
Growth Catalysts | Learn how NHS inclusion and potential FDA approval in Q1 2025 could accelerate Nyxoah's market penetration in key regions |
Nyxoah Earnings Call Summary for Q4/2023
- Nyxoah reported 43% sales growth to u20ac4.3M in Q4, with u20ac1.8M in Q4 sales representing 87% sequential and 42% YoY growth
- Company anticipates FDA approval and product launch by end of 2024, with final PMA module submission planned for Q2 2024
- Strong cash position of u20ac58M provides runway into late 2024; Q4 cash burn was u20ac4.9M
- Partnership with ResMed Germany expected to boost OSA therapy penetration; Nyxoah holds ~50% market share in Germany
- Positive DREAM study results reported; detailed data to be presented at ISSS conference in September
Last Updated: 06/03/2024, 21:58
Read Full TranscriptCompare NYXH to Peers and Sector
Metrics to compare | NYXH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNYXHPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.5x | −2.1x | −0.5x | |
PEG Ratio | 0.11 | 0.01 | 0.00 | |
Price/Book | 2.6x | 2.2x | 2.6x | |
Price / LTM Sales | 56.1x | 2.1x | 3.2x | |
Upside (Analyst Target) | 69.2% | 48.7% | 41.6% | |
Fair Value Upside | Unlock | 4.6% | 6.0% | Unlock |
Earnings
Latest Release
May 14, 2025
EPS / Forecast
-0.6706 / -0.5146
Revenue / Forecast
1.19M / 1.83M
FAQ
What Stock Exchange Does Nyxoah Trade On?
Nyxoah is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Nyxoah?
The stock symbol for Nyxoah is "NYXH."
What Is the Nyxoah Market Cap?
As of today, Nyxoah market cap is 284.69M.
What Is Nyxoah's Earnings Per Share (TTM)?
The Nyxoah EPS (TTM) is -2.00.
When Is the Next Nyxoah Earnings Date?
Nyxoah will release its next earnings report on 05 Aug 2025.
From a Technical Analysis Perspective, Is NYXH a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Nyxoah Stock Split?
Nyxoah has split 0 times.
How Many Employees Does Nyxoah Have?
Nyxoah has 184 employees.
What is the current trading status of Nyxoah (NYXH)?
As of 28 Jul 2025, Nyxoah (NYXH) is trading at a price of 7.58, with a previous close of 7.58. The stock has fluctuated within a day range of 7.50 to 7.77, while its 52-week range spans from 5.55 to 11.87.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.